Get the Stockscreener App
85.80
2.71%
2.26
After Hours:
86.00
0.20
+0.23%
Overview
News
Price History
Option Chain
Financials
Why CTVA Down?
Discussions
Forecast
Dividend History
Corteva Inc stock is traded at $85.80, with a volume of 3.16M.
It is up +2.71% in the last 24 hours and up +10.61% over the past month.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in late 2026. The seeds business will be named Vylor, while the crop protection business will retain the Corteva name and be a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
See More
Previous Close:
$83.54
Open:
$83.565
24h Volume:
3.16M
Relative Volume:
0.81
Market Cap:
$57.38B
Revenue:
$17.89B
Net Income/Loss:
$1.26B
P/E Ratio:
50.38
EPS:
1.7029
Net Cash Flow:
$2.05B
1W Performance:
+5.12%
1M Performance:
+10.61%
6M Performance:
+26.62%
1Y Performance:
+11.43%
1-Day Range:
$83.11
$85.83
1-Week Range:
$81.01
$85.95
52-Week Range:
$60.53
$85.95
Corteva Inc Stock (CTVA) Company Profile
Name
Corteva Inc
Sector
Industry
Phone
(833) 267-8382
Address
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA vs NTR, CF, MOS, ICL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
85.80 | 56.64B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
65.06 | 30.22B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
110.54 | 16.63B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
21.13 | 6.74B | 12.05B | 575.40M | -534.60M | 1.6871 |
ICL
Icl Group Ltd
|
5.03 | 6.43B | 7.41B | 314.00M | 220.88M | 0.202 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Downgrade | UBS | Buy → Neutral |
| Feb-05-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-03-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-02-25 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-13-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Mar-13-25 | Initiated | Goldman | Buy |
| Oct-23-24 | Initiated | Citigroup | Buy |
| Oct-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-07-24 | Downgrade | Argus | Buy → Hold |
| Apr-12-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-01-24 | Initiated | Wolfe Research | Outperform |
| Feb-12-24 | Upgrade | Loop Capital | Hold → Buy |
| Feb-02-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Nov-27-23 | Downgrade | Berenberg | Buy → Hold |
| Nov-14-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-20-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-05-23 | Upgrade | UBS | Neutral → Buy |
| Jul-25-23 | Downgrade | Redburn | Buy → Neutral |
| Jun-28-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Upgrade | Vertical Research | Hold → Buy |
| Apr-06-23 | Initiated | Oppenheimer | Perform |
| Jan-19-23 | Initiated | Wells Fargo | Overweight |
| Jan-11-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-16-22 | Downgrade | UBS | Buy → Neutral |
| Nov-15-22 | Downgrade | Loop Capital | Buy → Hold |
| Aug-08-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-08-22 | Upgrade | ROTH Capital | Neutral → Buy |
| Jul-14-22 | Initiated | Credit Suisse | Outperform |
| Jun-01-22 | Initiated | Barclays | Overweight |
| May-06-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-22 | Upgrade | Loop Capital | Hold → Buy |
| Apr-14-22 | Downgrade | Vertical Research | Buy → Hold |
| Jan-31-22 | Upgrade | Redburn | Neutral → Buy |
| Oct-18-21 | Downgrade | Loop Capital | Buy → Hold |
| Oct-13-21 | Initiated | Mizuho | Buy |
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Sep-01-21 | Initiated | Berenberg | Buy |
| Aug-09-21 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
| May-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Apr-19-21 | Upgrade | Loop Capital | Hold → Buy |
| Feb-05-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-05-21 | Reiterated | Monness Crespi & Hardt | Sell |
| Dec-18-20 | Downgrade | Susquehanna | Positive → Neutral |
| Dec-14-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-10-20 | Upgrade | Argus | Hold → Buy |
| Oct-19-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-19-20 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
| Aug-11-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Aug-10-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-13-20 | Upgrade | BofA Securities | Underperform → Buy |
| Jun-26-20 | Initiated | Cleveland Research | Neutral |
| Jun-16-20 | Upgrade | Vertical Research | Hold → Buy |
| Jun-08-20 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| May-11-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Apr-17-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Apr-17-20 | Upgrade | Loop Capital | Sell → Hold |
| Apr-01-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-31-20 | Upgrade | Susquehanna | Neutral → Positive |
| Mar-26-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-19-20 | Upgrade | Edward Jones | Hold → Buy |
| Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-10-20 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
View All
Corteva Inc Stock (CTVA) Latest News
Corteva stock hits all-time high at 85.64 USD - Investing.com UK
Corteva stock hits all-time high at 85.64 USD By Investing.com - Investing.com Canada
Pesticide Giant Syngenta Appoints New CEO - marketscreener.com
Farm Hands on the Potomac: Olivia Bridges joins Agri-Pulse team, Corteva announces boards of directors, Donna Garren appointed to FDA role - Agri-Pulse
Corteva names boards of directors for new crop protection and seed companies - Indianapolis Business Journal
Corteva Inc. stock outperforms competitors on strong trading day - MarketWatch
Disruption in the Agricultural Sector: Why Corteva and Deere & Company Are Keeping an Eye on MustGrow Biologics - news.financial
Corteva names board for crop protection spinoff - Investing.com UK
Corteva (CTVA) Announces Board Resignations Ahead of Seed Busine - GuruFocus
Corteva Details Board for Future Crop Protection Spinoff - TipRanks
Corteva names board for crop protection spinoff By Investing.com - Investing.com Australia
Karen Grimes, Marcos Lutz, Charles Magro and Kerry Preete to Resign from Corteva Board Ahead of Vylor Spin-Off - TradingView
Corteva (CTVA) details Corteva and Vylor boards as 4Q 2026 spin-off nears - Stock Titan
Corteva picks board for Vylor as seed spin-off stays on track for 4Q 2026 - Stock Titan
Citigroup maintains Corteva (CTVA) neutral recommendation - MSN
Corteva, Inc.(NYSE: CTVA) dropped from Russell 1000 Dynamic Index - marketscreener.com
Enterprise value to EBIT forward of Corteva, Inc. – NYSE:CTVA - TradingView
FMC and Corteva partner to expand access to Rimisoxafen technology - MSN
How Investors May Respond To Corteva (CTVA) Rimisoxafen Supply Deal And US$200 Million Prepurchase - simplywall.st
Corteva Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
CTVA Technical Analysis & Stock Price Forecast - Intellectia AI
Price to earnings forward of Corteva, Inc. – NYSE:CTVA - TradingView
Corteva Stock And Other Pesticide Names Getting Relief From Supreme Court Lawsuit Limits - Sahm
Price to sales forward of Corteva, Inc. – BOATS:CTVA - TradingView
Corteva Shares Rise Following Landmark Supreme Court Pesticide Ruling - Sahm
Price to earnings forward of Corteva, Inc. – BOATS:CTVA - TradingView
Enterprise value to EBIT forward of Corteva, Inc. – BOATS:CTVA - TradingView
Price to book forward of Corteva, Inc. – NYSE:CTVA - TradingView
Corteva Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.25 Sh Actuals & Estimates (BMFBOVESPA:C1TV34) - TradingView
Corteva Inc Actuals & Estimates (NYSE:CTVA) - TradingView
Understanding the Setup: (CTVA) and Scalable Risk - Stock Traders Daily
Enterprise value to revenue forward of Corteva Inc – LS:A2PKRR - TradingView
CTVA Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Corteva Inc – LS:A2PKRR - TradingView
Corteva Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Exclusive | Corteva, a $50 Billion Seed-and-Pesticide Maker, Is Exploring a Breakup - WSJ
Corteva Inc (CTVA) Institutional Confidence - TradingKey
Is Mission Produce Winning Through Operational Efficiency Gains? - TradingView
Hsbc Holdings PLC Cuts Position in Corteva, Inc. $CTVA - MarketBeat
Corteva (CTVA) Stock Could Be 13% Undervalued After FMC Herbicide Deal - Sahm
Will FMC's (FMC) Rimisoxafen Deal With Corteva Reshape Its Cash Flow Repair Narrative? - simplywall.st
Why Corteva’s Lumialza seed treatment is drawing fresh attention from corn growers - AD HOC NEWS
What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders - Sahm
US' FMC, Corteva partner to expand rimisoxafen weed control - ALCHEMPro
How MustGrow Biologics Benefits from Agrochemical Realignment with Patented Bioactive Technology – Pressure on Bayer and Corteva - news.financial
FMC and Corteva Partner to Expand Access to Rimisoxafen Technology - Yahoo Finance
Corteva Inc (CTVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Corteva Inc (CTVA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Corteva Inc (CTVA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Corteva Inc (CTVA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Corteva stock ticks up to $77.45 as CortevaUS promotes photo contest for branded T-shirts - Traders Union
Corteva Inc Stock (CTVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.34%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):